Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Conjugate or complex
Patent
1998-03-19
2000-02-29
Lankford, Jr., Leon B.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Conjugate or complex
514 27, A61K 3578, A61K 3170, A01N 4304
Patent
active
060306211
ABSTRACT:
This invention provides different compositions extracted from Ginkgo biloba leaves. Said compositions comprise new active components. This invention also provides a method of preparation of the compositions and individual components of said compositions. Finally, this invention provides various uses of this composition.
REFERENCES:
patent: 4981688 (1991-01-01), Ayroles et al.
patent: 5002965 (1991-03-01), Ramwell et al.
patent: 5089636 (1992-02-01), Kwak et al.
patent: 5098709 (1992-03-01), Kang
patent: 5128131 (1992-07-01), Motoyama et al.
patent: 5158770 (1992-10-01), Saito et al.
patent: 5194259 (1993-03-01), Soudant et al.
patent: 5241084 (1993-08-01), Teng
patent: 5322688 (1994-06-01), Schwabe
patent: 5389370 (1995-02-01), O'Reilly et al.
patent: 5399348 (1995-03-01), Schwabe
patent: 5466829 (1995-11-01), Park et al.
patent: 5512286 (1996-04-01), Schwabe
patent: 5541183 (1996-07-01), Park et al.
patent: 5599950 (1997-02-01), Teng
Pietri, S. et al. Effect of Ginkgo biloba extract (EGb 761) on free radical-induced ischemia-repertusion injury in isolated rat hearts: a hemodynamic and electron-spin-resonance investigation, in Advances in Ginkgo biloba Extract Research, vol. 2. Ginkgo bibloba Extract (EGb 761) as a Free-Radical Scavenger, C. Ferradini et al eds. Elsevier, Paris 1993, pp. 163-171.
Spinnewyn, B. et al, Effect of Ginkgo biloba extract (EGb 761) on oxygen consumption by isolated cerebral mitochondria, in Advances in Ginbgo biolha Extract Research, vol. 4, Effects of Ginkgo biloba Extract (EGb 761) on Aging and Age-Related Disorders, Y. Christen et al eds. Elsevier, Paris, 1995, pp. 17-22.
Defeudis, F. V. In Vitro Stusies with EGb 761, in Ginkgo biloba Extract (EGb 761): Pharmacological Activities and Clinical Applications, F.V. DeFeudis, Elsevier, Paris, 1991, pp. 25-60.
Defeudis, F. V. In Vivo Studies with EGb 761, in Ginkgo biloba Extract (EGB 761): Pharmacological Activities and Clinical Applications, F. V. DeFeudis, Elsevier, Paris, 1991, pp. 61-78.
Defeusis, F. V. Safty of EGb 761--Containing Products, ibid. pp. 143-146.
Defeudis, F. V. Machanisms and Concepts of Action of EGb 761: Theoretical Considerations, ibid. pp. 147-152.
Defeudis, F.V. Clinical Studies and Clinical Pharmacology with EGb 761, ibid. pp. 97-125.
An Zhang Guo
De Long Xie
Ning Wang
Ping Shao Bao
Qi Gao
Elkins Mark
Lankford , Jr. Leon B.
Tate Christopher R.
LandOfFree
Ginkgo biloba composition, method to prepare the same and uses t does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Ginkgo biloba composition, method to prepare the same and uses t, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Ginkgo biloba composition, method to prepare the same and uses t will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-680255